TY - JOUR
T1 - Comparative community outreach to increase cervical cancer screening in the Mississippi Delta
AU - Castle, Philip E.
AU - Rausa, Alfio
AU - Walls, Tameka
AU - Gravitt, Patti E.
AU - Partridge, Edward E.
AU - Olivo, Vanessa
AU - Niwa, Shelley
AU - Morrissey, Kerry Grace
AU - Tucker, Laura
AU - Katki, Hormuzd
AU - Scarinci, Isabel
N1 - Funding Information:
This research was supported by the Intramural Research Program of the NIH , NCI and by the NCI Center for Reducing Cancer Health Disparities (CRCHD) . The authors acknowledge former members of CRCHD, Dr. Harold Freeman and Ms. Jane Daye for their unwavering support of this effort.
PY - 2011/6/1
Y1 - 2011/6/1
N2 - Objective: The aim of the study was to increase participation in cervical cancer screening of under-screened women living in the Mississippi Delta, a U.S. population at high risk for cervical cancer. Methods: We conducted a door-to-door feasibility study of women living in the Mississippi Delta to increase participation in cervical cancer screening in 2009-10. Women (n= 119) aged 26-65. years who had not been screened in last 3. years or more, were not pregnant, and had a cervix were offered a cost-free choice: clinic-based Pap testing or home self-collection with HPV DNA testing. Results: Seventy-seven women (64.7%) chose self-collection with HPV testing, of which sixty-two (80.5%) returned their self-collected specimen. By comparison, 42 women (35.3%) chose Pap testing, of which 17 (40.5%) attended their clinic appointment. Thus there was an almost 4-fold greater participation of under-screened women in self-collection with HPV testing than in free Pap testing (78.4% vs. 21.5%). Conclusions: We found that offering self-collection will increase participation in cervical cancer screening among under-screened populations living in the Mississippi Delta. Based on these preliminary results, we suggest that self-collection with HPV DNA testing might complement current Pap testing programs to reach under-screened populations of women, such as those living in the Mississippi Delta.
AB - Objective: The aim of the study was to increase participation in cervical cancer screening of under-screened women living in the Mississippi Delta, a U.S. population at high risk for cervical cancer. Methods: We conducted a door-to-door feasibility study of women living in the Mississippi Delta to increase participation in cervical cancer screening in 2009-10. Women (n= 119) aged 26-65. years who had not been screened in last 3. years or more, were not pregnant, and had a cervix were offered a cost-free choice: clinic-based Pap testing or home self-collection with HPV DNA testing. Results: Seventy-seven women (64.7%) chose self-collection with HPV testing, of which sixty-two (80.5%) returned their self-collected specimen. By comparison, 42 women (35.3%) chose Pap testing, of which 17 (40.5%) attended their clinic appointment. Thus there was an almost 4-fold greater participation of under-screened women in self-collection with HPV testing than in free Pap testing (78.4% vs. 21.5%). Conclusions: We found that offering self-collection will increase participation in cervical cancer screening among under-screened populations living in the Mississippi Delta. Based on these preliminary results, we suggest that self-collection with HPV DNA testing might complement current Pap testing programs to reach under-screened populations of women, such as those living in the Mississippi Delta.
KW - Atypical squamous cells of undetermined significance (ASC-US)
KW - Cervical cancer
KW - Cervical cancer screening
KW - Cervical intraepithelial neoplasia (CIN)
KW - Health disparities
KW - Human papillomavirus (HPV)
KW - Hybrid Capture 2 (HC2)
KW - Pap
UR - http://www.scopus.com/inward/record.url?scp=79957887743&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79957887743&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2011.03.018
DO - 10.1016/j.ypmed.2011.03.018
M3 - Article
C2 - 21497619
AN - SCOPUS:79957887743
SN - 0091-7435
VL - 52
SP - 452
EP - 455
JO - Preventive Medicine
JF - Preventive Medicine
IS - 6
ER -